# OnCo record gsk (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gsk/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gsk" ;
  schema:name "GSK"@en ;
  schema:alternateName "Tesaro, Inc."@en, "Tesaro"@en, "Bellus Health Inc. - a GSK company"@en, "Bellus Health"@en ;
  schema:description "GSK makes Jemperli, Zejula, and the twice-approved myeloma ADC Blenrep."@en ;
  schema:url <https://onco.cc/companies/gsk/>, <https://www.gsk.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/GSK_plc> ;
  owl:sameAs <http://www.wikidata.org/entity/Q212322> ;
  schema:citation <https://www.gsk.com> ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/drugs/niraparib/>, <https://onco.cc/drugs/belantamab-mafodotin/>, <https://onco.cc/drugs/velzatinib/>, <https://onco.cc/drugs/cobolimab/>, <https://onco.cc/drugs/idrx-42/>, <https://onco.cc/drugs/feladilimab/>, <https://onco.cc/drugs/topotecan/>, <https://onco.cc/drugs/chlorambucil/>, <https://onco.cc/drugs/ondansetron/> ;
  onco:trials <https://onco.cc/trials/nct06868654/>, <https://onco.cc/trials/nct06956170/>, <https://onco.cc/trials/nct04162210/>, <https://onco.cc/trials/nct06679101/>, <https://onco.cc/trials/nct06868667/>, <https://onco.cc/trials/nct07084896/>, <https://onco.cc/trials/nct06521567/>, <https://onco.cc/trials/nct07150091/>, <https://onco.cc/trials/nct07227311/>, <https://onco.cc/trials/nct07217184/>, <https://onco.cc/trials/nct05714839/>, <https://onco.cc/trials/nct07150104/>, <https://onco.cc/trials/nct05565378/>, <https://onco.cc/trials/nct06640049/>, <https://onco.cc/trials/nct06062420/>, <https://onco.cc/trials/nct06256588/>, <https://onco.cc/trials/nct07263594/>, <https://onco.cc/trials/nct07108270/>, <https://onco.cc/trials/nct06567782/>, <https://onco.cc/trials/nct06317311/>, <https://onco.cc/trials/nct07286331/>, <https://onco.cc/trials/nct06710847/>, <https://onco.cc/trials/nct07689201/>, <https://onco.cc/trials/nct07213609/>, <https://onco.cc/trials/nct06990880/>, <https://onco.cc/trials/nct04915755/>, <https://onco.cc/trials/nct07332455/>, <https://onco.cc/trials/nct07099898/>, <https://onco.cc/trials/nct03602859/>, <https://onco.cc/trials/nct06885034/>, <https://onco.cc/trials/nct07602777/>, <https://onco.cc/trials/nct05855200/>, <https://onco.cc/trials/nct04641247/>, <https://onco.cc/trials/nct06472076/>, <https://onco.cc/trials/nct03441113/>, <https://onco.cc/trials/nct07286266/>, <https://onco.cc/trials/nct06077877/>, <https://onco.cc/trials/nct06796907/> .